Pfizer-BioNTech COVID-19 vaccine 100% efficacious in adolescents, finds trial Medha Baranwal1 April 2021 2:30 PM ISTUSA: BNT162b2 vaccine has demonstrated 100% efficacy and robust antibody responses in adolescents aged 12 to 15 years of age with or without prior...
AIIMS director says 5 COVID vaccines undergoing trial in India logistically feasible for distribution Medical Dialogues Bureau6 Dec 2020 9:00 AM ISTNew Delhi: AIIMS Director Dr Randeep Guleria on Thursday pinned his hopes on the five COVID-19 vaccine candidates which are in advanced stages...
COVID-19 vaccine found to be 90% effective: Pfizer Dr. Nandita Mohan12 Nov 2020 5:23 PM ISTAccording to a recent interim analysis of a phase 3 study, a vaccine for SARS-CoV-2 shows 90% efficacy in fighting the virus when experimented on...
Pfizer, BioNTech begin German part of COVID vaccine study Medical Dialogues Bureau13 Sept 2020 9:00 AM ISTGermany's vaccines regulator, the Paul Ehrlich Institute, gave the approval for the Phase 2/3 trial of the experimental vaccine known as BNT162b2,...
Pfizer-BioNTech potential COVID vaccine shows promise in second early trial Medical Dialogues Bureau1 Aug 2020 9:45 AM ISTNew York: German biotech BioNTech and U.S. drugmaker Pfizer Inc recently said data from an early-stage trial of their experimental coronavirus vaccine...
